Chinese | English
2025
首页 > Investor Relations > Announcements And Circulars > 2025
2025
AMENDED AND RESTATED MEMORANDUM AND ARTI12-11 POLL RESULTS OF THE ANNUAL GENERAL MEETI12-11
Monthly Return for Equity Issuer and Hon12-03 FORM OF PROXY FOR USE AT ANNUAL GENERAL 11-14
NOTICE OF ANNUAL GENERAL MEETING11-14 PROPOSALS FOR (1) GRANTING OF GENERAL MA11-14
PROPOSED AMENDMENTS TO THE EXISTING ARTI11-10 Monthly Return for Equity Issuer and Hon11-03
ANNUAL REPORT10-21 Monthly Return for Equity Issuer and Hon10-03
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR09-30 PROFIT WARNING09-29
NOTICE OF BOARD MEETING09-19 Next Day Disclosure Return09-18
Monthly Return for Equity Issuer and Hon09-03 Monthly Return for Equity Issuer and Hon09-01
POLL RESULTS OF EXTRAORDINARY GENERAL ME08-19 Monthly Return for Equity Issuer and Hon08-01
FORM OF PROXY FOR USE AT EXTRAORDINARY G07-31 NOTICE OF EXTRAORDINARY GENERAL MEETING07-31
PROPOSED INCREASE OF AUTHORISED SHARE CA07-31 PROPOSED INCREASE IN AUTHORISED SHARE CA07-31
POLL RESULTS OF THE EXTRAORDINARY GENERA07-23 REVISED FORM OF PROXY FOR USE AT EXTRAOR07-08
FORM OF PROXY FOR USE AT EXTRAORDINARY G07-04
 48    1 2 下一页 尾页

联系我们 | 资料下载 | 隐私保护 | 网站地图

Jintian Pharmaceutical Group., 2016. All rights reserved.(黑ICP备05064281号)